bullish
Junshi Bio (君实医药) Placement - Expected Deal but Large Deal Size
249 Views15 Jun 2021 18:57
Shanghai Junshi Bioscience Co. Ltd. (1877 HK) is looking to raise about US$280m in its primary placement. Proceeds raised will be mainly used for R&D.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Zhen Zhou, Toh
APAC IPOs & Placements
Price Chart(Sign Up to Access)
- Industry Report - Insights on China Meal Replacement Industry01 Jul 2021
- 3SBio Inc (1530.HK) - The Concerns and the Outlook29 Jun 2021
- Industry Report - Insights on Hair Loss Prevention and Hair Growth Industry17 Jun 2021
- Shanghai Junshi Bioscience - Here Are the Challenges24 Mar 2021
- Junshi Bioscience Lock-Up Expiry: Valuation Still Rich with Few R&D Updates24 Jun 2019
- Autonomous Driving- The Tesla Delusion06 Apr 2018
x